STAT3-IN-18
STAT3-IN-18 (compound SPP) is a platinum (IV) complex with an axial ligand derived from sandalwood. STAT3-IN-18 inhibits the JAK2-STAT3 pathway in breast cancer (BC) cells, with anti-proliferative activity. STAT3-IN-18 activates caspase-3 and increases cleaved polyADP-ribose polymerase to induce apoptosis. STAT3-IN-18 promotes maturation and antigen presentation of dendritic cells and demonstrates safety in vivo.
Product Specifications
CAS Number
2668267-41-0
UNSPSC
12352005
Target
Apoptosis; COX; JAK; STAT
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; Immunology/Inflammation; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/stat3-in-18.html
Solubility
10 mM in DMSO
Smiles
[Cl-][Pt+4]([Cl-])([NH3])([NH3])([OH-])[O-]C(COC(C=C1)=CC=C1/C=C/C2=CC(OC)=CC(OC)=C2)=O
Molecular Formula
C18H24Cl2N2O6Pt
Molecular Weight
630.38
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GM-CSF (Csf2, Granulocyte-macrophage Colony-stimulating Factor, Colony-stimulating Factor, CSF, Csfgm, MGC151255, MGC151257) (APC)
GM-CSF (Csf2, Granulocyte-macrophage Colony-stimulating Factor, Colony-stimulating Factor, CSF, Csfgm, MGC151255, MGC151257) (APC)
KRTAP4-1 sgRNA CRISPR Lentivector (Human) (Target 2)